AKT1 and hepatocellular carcinoma: In fact, numerous studies have demonstrated that HCC cells with acquired sorafenib resistance exhibit significantly higher levels of phosphorylation AKT than parental cells, although suppression of AKT can reverse acquired sorafenib resistance (27, 28).